Sales and Marketing

Showing 15 posts of 11524 posts found.

sanofi_regeneron

New potential blockbuster RA treatment enters European market

June 27, 2017 Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi

The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …
kress

Biogen appoint new Head of Global Therapeutic Operations

June 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress

Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …
novartis_side_building

UK launch of two Novartis biosimilars could cut NHS costs

June 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …
thumbs_up

Duchenne drug made available to UK patients early

June 27, 2017 Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone

UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …
shutterstock_57369385

Drug Combinations and Emerging Interactions

June 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …

Humira set to face new European biosimilar rival

June 26, 2017 Sales and Marketing CHMP, EMA, Samsung Bioepis

A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to …
roche

Roche haemophilia therapy cuts bleed rate by 87%

June 26, 2017 Research and Development, Sales and Marketing Roche, haemophilia

Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …
nhs_parliament_2_4

Public dissatisfaction with NHS found to be growing, says BMA

June 26, 2017 Medical Communications, Sales and Marketing BMA, NHS

The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …
novo_nordisk_flag

Promising Phase 2 obesity data for Novo’s diabetes drug

June 26, 2017 Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …

Astellas receives further year suspension from ABPI

June 26, 2017 Medical Communications, Sales and Marketing ABPI, Astellas

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017 Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017 Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …
novartis_headquarters

Novartis pulls off surprise success in cardiovascular risk

June 22, 2017 Research and Development, Sales and Marketing Novartis

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …
The Gateway to Local Adoption Series

Latest content